OpenURL Connection Search

Select item for more details and to access through your institution.

Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1324631
By:
- Droghetti, Matteo;
- Bianchi, Lorenzo;
- Presutti, Massimiliano;
- Vetrone, Luigia;
- Farolfi, Andrea;
- Mei, Riccardo;
- Giunchi, Francesca;
- Degiovanni, Alessio;
- Mottaran, Angelo;
- Piazza, Pietro;
- Cangemi, Danilo;
- Castellucci, Paolo;
- D’Errico, Antonietta;
- Schiavina, Riccardo;
- Brunocilla, Eugenio;
- Fanti, Stefano
Publication type:
Article
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.
Published in:
Cancers, 2023, v. 15, n. 7, p. 2027, doi. 10.3390/cancers15072027
By:
- Bianchi, Lorenzo;
- Ceci, Francesco;
- Balestrazzi, Eleonora;
- Costa, Francesco;
- Droghetti, Matteo;
- Piazza, Pietro;
- Pissavini, Alessandro;
- Presutti, Massimiliano;
- Farolfi, Andrea;
- Mei, Riccardo;
- Castellucci, Paolo;
- Gandaglia, Giorgio;
- Larcher, Alessandro;
- Robesti, Daniele;
- Mottrie, Alexandre;
- Briganti, Alberto;
- Morganti, Alessio Giuseppe;
- Fanti, Stefano;
- Montorsi, Francesco;
- Schiavina, Riccardo
Publication type:
Article
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68 Ga-PSMA PET/CT Features in Primary Staging.
Published in:
Cancers, 2023, v. 15, n. 6, p. 1716, doi. 10.3390/cancers15061716
By:
- Vetrone, Luigia;
- Mei, Riccardo;
- Bianchi, Lorenzo;
- Giunchi, Francesca;
- Farolfi, Andrea;
- Castellucci, Paolo;
- Droghetti, Matteo;
- Presutti, Massimiliano;
- Degiovanni, Alessio;
- Schiavina, Riccardo;
- Brunocilla, Eugenio;
- D'Errico, Antonietta;
- Fanti, Stefano
Publication type:
Article

Found: 3

Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68 Ga-PSMA PET/CT Features in Primary Staging.